Recently, the ER-associated molecule STING has been found to stimulate the production of type I IFN in the tumour [56,57] and results in anti-tumour responses through the activation of IFN-α signalling pathways in macrophages [58,59]. This evidence concerns the gene STING1 and neoplasm.